淋巴瘤患者的性功能障碍与性困扰：一项横断面研究。
Sexual Dysfunction and Sexual Distress Among Patients With Lymphoma: A Cross-Sectional Study.
作者信息
Durosier Mertilus Dorothie S, Szalacha Laura A, Donovan Kristine A, Lengacher Cecile A, Tinsley-Vance Sara M, Sokol Lubomir, Rodriguez Carmen S
机构信息
Dorothie S. Durosier Mertilus.
Laura A. Szalacha.
出版信息
Oncol Nurs Forum. 2025 Jun 12;52(4):248-258. doi: 10.1188/25.ONF.248-258.
OBJECTIVES
To evaluate the prevalence of sexual dysfunction and sexual distress among male and female patients with lymphoma during cancer treatment.
SAMPLE & SETTING: A sample of 20 patients with lymphoma was recruited from the Malignant Hematology Department of a National Cancer Institute-designated comprehensive cancer center to participate in this study.
METHODS & VARIABLES: This study was one part of a pilot mixed-methods study and used a quantitative-descriptive, cross-sectional design. Data on sexual dysfunction and sexual distress were collected using four validated self-report questionnaires and analyzed using descriptive and inferential statistics.
RESULTS
Sexual dysfunction (n = 9 of 14 among male versus all female participants) and sexual distress (n = 6 of 14 among male versus n = 4 of 6 among female participants) were prevalent among patients with lymphoma undergoing cancer treatment.
IMPLICATIONS FOR NURSING
Sexual function should be routinely assessed during every visit. In addition, sexual health should be integrated in survivorship care plans.
目的
评估淋巴瘤男女患者在癌症治疗期间性功能障碍和性困扰的患病率。
样本与背景
从一家国家癌症研究所指定的综合癌症中心的恶性血液科招募了20名淋巴瘤患者作为样本参与本研究。
方法与变量
本研究是一项试点混合方法研究的一部分，采用定量描述性横断面设计。使用四份经过验证的自我报告问卷收集性功能障碍和性困扰的数据，并使用描述性和推断性统计进行分析。
结果
在接受癌症治疗的淋巴瘤患者中，性功能障碍（男性参与者中14人中有9人，女性参与者全部）和性困扰（男性参与者中14人中有6人，女性参与者中6人中有4人）很普遍。
对护理的启示
每次就诊时都应常规评估性功能。此外，性健康应纳入生存护理计划。
Zotero 插件